What Treatments for MPN in late stage clinical trials look most promising in 2022?
by David Wallace
Patients are Asking – MPN Specialist Dr. Michael Grunwald, from Levine Cancer Institute discusses new medications for myeloproliferative neoplasms
Episode 1 of 3
Dr. Grunwald also provides insight into how to get a referral to see an MPN expert.
Featuring: Dr. Michael Grunwald
Thank you to our Sponsors
